[Correspondence] Off-target benefits of influenza vaccination in cardiovascular disease
We read with interest Craig S Anderson and colleagues’ PANDA II cluster-randomised trial of influenza vaccination in heart failure.1 Vaccination during admission improved survival and reduced readmissions at 12 months, with a number needed to vaccinate of 27. This is a rigorous and clinically import
ORIGINAL SOURCE →via The Lancet
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · health
- [HEALTH] Knowledge, Attitudes, and Practices Regarding Arboviruses at a Human-Wildlife Interface: A Cross-Sectional Study in and
- [HEALTH] How to shore up trust during the "cold-period" between pandemics - closing the public trust gap in pandemic preparedness
- [HEALTH] Emergency department evaluation and management of serious and high-risk infections in the febrile returning traveler.
- [HEALTH] Trk1 potassium transport is crucial for effective Candidozyma auris skin colonization.
- [HEALTH] [A rapid visual detection method for porcine circovirus type 4 based on enzymatic recombinase amplification and CRISPR/E
- [HEALTH] [Editorial] The US CDC on the brink